These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 30152016)
21. Two Chinese Xia-Gibbs syndrome patients with partial growth hormone deficiency. Cheng X; Tang F; Hu X; Li H; Li M; Fu Y; Yan L; Li Z; Gou P; Su N; Gong C; He W; Xiang R; Bu D; Shen Y Mol Genet Genomic Med; 2019 Apr; 7(4):e00596. PubMed ID: 30729726 [TBL] [Abstract][Full Text] [Related]
22. Xia-Gibbs syndrome in adulthood: a case report with insight into the natural history of the condition. Murdock DR; Jiang Y; Wangler M; Khayat MM; Sabo A; Juusola J; McWalter K; Schatz KS; Gunay-Aygun M; Gibbs RA Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 30622101 [TBL] [Abstract][Full Text] [Related]
23. Different epilepsy course of a novel AHDC1 mutation in a female monozygotic twin pair. Salvati A; Biagioni T; Ferrari AR; Lopergolo D; Brovedani P; Bartolini E Seizure; 2022 Jul; 99():127-130. PubMed ID: 35636160 [TBL] [Abstract][Full Text] [Related]
24. Retrospective identification of patients with SRRM2-related neurodevelopmental disorder in a single tertiary children's hospital. Regan-Fendt KE; Rippert AL; Medne L; Skraban CM; DeJesse J; Gray C; Reichert SL; Staropoli NP; Santos FJR; Krantz ID; Murrell JR; Izumi K Am J Med Genet A; 2023 Aug; 191(8):2149-2155. PubMed ID: 37212523 [TBL] [Abstract][Full Text] [Related]
25. Novel Insights from Clinical Practice: Xia-Gibbs Syndrome with Pes Cavus, Conjunctival Melanosis, and Eye Asymmetry due to a de novo AHDC1 Gene Variant - A Case Report and a Brief Review of the Literature. Baga M; Ivanovski I; Contrò G; Caraffi SG; Spagnoli C; Cesaroni CA; Neri A; Peluso F; Pollazzon M; Garavelli L; Fusco C Mol Syndromol; 2024 Feb; 15(1):63-70. PubMed ID: 38357260 [TBL] [Abstract][Full Text] [Related]
26. [Analysis of a case with Xia-Gibbs syndrome due to variant of AHDC1 gene]. Fan L; Li Y; Luo H; Shen Y; Yuan M; Yang Z; Gan J Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Apr; 39(4):397-400. PubMed ID: 35446974 [TBL] [Abstract][Full Text] [Related]
27. Establishment of iPSC lines and zebrafish with loss-of-function AHDC1 variants: Models for Xia-Gibbs syndrome. Carvalho LML; Branco EV; Sarafian RD; Kobayashi GS; de Araújo FT; Santos Souza L; Moreira DP; Hsia GSP; Bertollo EMG; Buck CB; da Costa SS; Fialho DM; de Vasconcelos FTGR; Brito LA; de Souza Fraga Machado LE; Ramos IC; Pereira LDV; Koiffmann CP; E Passos-Bueno MRDS; Oliveira Mendes TA; Krepischi ACV; Rosenberg C Gene; 2023 Jun; 871():147424. PubMed ID: 37054903 [TBL] [Abstract][Full Text] [Related]
28. Genotype and phenotype correlations for SHANK3 de novo mutations in neurodevelopmental disorders. Li Y; Jia X; Wu H; Xun G; Ou J; Zhang Q; Li H; Bai T; Hu Z; Zou X; Xia K; Guo H Am J Med Genet A; 2018 Dec; 176(12):2668-2676. PubMed ID: 30537371 [TBL] [Abstract][Full Text] [Related]
29. CREBBP mutations in individuals without Rubinstein-Taybi syndrome phenotype. Menke LA; van Belzen MJ; Alders M; Cristofoli F; ; Ehmke N; Fergelot P; Foster A; Gerkes EH; Hoffer MJ; Horn D; Kant SG; Lacombe D; Leon E; Maas SM; Melis D; Muto V; Park SM; Peeters H; Peters DJ; Pfundt R; van Ravenswaaij-Arts CM; Tartaglia M; Hennekam RC Am J Med Genet A; 2016 Oct; 170(10):2681-93. PubMed ID: 27311832 [TBL] [Abstract][Full Text] [Related]
30. MAB21L1 loss of function causes a syndromic neurodevelopmental disorder with distinctive Rad A; Altunoglu U; Miller R; Maroofian R; James KN; Çağlayan AO; Najafi M; Stanley V; Boustany RM; Yeşil G; Sahebzamani A; Ercan-Sencicek G; Saeidi K; Wu K; Bauer P; Bakey Z; Gleeson JG; Hauser N; Gunel M; Kayserili H; Schmidts M J Med Genet; 2019 May; 56(5):332-339. PubMed ID: 30487245 [TBL] [Abstract][Full Text] [Related]
31. De Novo and Inherited Loss-of-Function Variants in TLK2: Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder. Reijnders MRF; Miller KA; Alvi M; Goos JAC; Lees MM; de Burca A; Henderson A; Kraus A; Mikat B; de Vries BBA; Isidor B; Kerr B; Marcelis C; Schluth-Bolard C; Deshpande C; Ruivenkamp CAL; Wieczorek D; ; Baralle D; Blair EM; Engels H; Lüdecke HJ; Eason J; Santen GWE; Clayton-Smith J; Chandler K; Tatton-Brown K; Payne K; Helbig K; Radtke K; Nugent KM; Cremer K; Strom TM; Bird LM; Sinnema M; Bitner-Glindzicz M; van Dooren MF; Alders M; Koopmans M; Brick L; Kozenko M; Harline ML; Klaassens M; Steinraths M; Cooper NS; Edery P; Yap P; Terhal PA; van der Spek PJ; Lakeman P; Taylor RL; Littlejohn RO; Pfundt R; Mercimek-Andrews S; Stegmann APA; Kant SG; McLean S; Joss S; Swagemakers SMA; Douzgou S; Wall SA; Küry S; Calpena E; Koelling N; McGowan SJ; Twigg SRF; Mathijssen IMJ; Nellaker C; Brunner HG; Wilkie AOM Am J Hum Genet; 2018 Jun; 102(6):1195-1203. PubMed ID: 29861108 [TBL] [Abstract][Full Text] [Related]
32. CHEDDA syndrome is an underrecognized neurodevelopmental disorder with a highly restricted ATN1 mutation spectrum. Palmer EE; Whitton C; Hashem MO; Clark RD; Ramanathan S; Starr LJ; Velasco D; De Dios JK; Singh E; Cormier-Daire V; Chopra M; Rodan LH; Nellaker C; Lakhani S; Mallack EJ; Panzer K; Sidhu A; Wentzensen IM; Lacombe D; Michaud V; Alkuraya FS Clin Genet; 2021 Oct; 100(4):468-477. PubMed ID: 34212383 [TBL] [Abstract][Full Text] [Related]
33. WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome. DeSanto C; D'Aco K; Araujo GC; Shannon N; ; Vernon H; Rahrig A; Monaghan KG; Niu Z; Vitazka P; Dodd J; Tang S; Manwaring L; Martir-Negron A; Schnur RE; Juusola J; Schroeder A; Pan V; Helbig KL; Friedman B; Shinawi M J Med Genet; 2015 Nov; 52(11):754-61. PubMed ID: 26264232 [TBL] [Abstract][Full Text] [Related]
34. Expanding the clinical phenotype and genetic spectrum of PURA-related neurodevelopmental disorders. Choi SA; Lee HS; Park TJ; Park S; Ko YJ; Kim SY; Lim BC; Kim KJ; Chae JH Brain Dev; 2021 Oct; 43(9):912-918. PubMed ID: 34116881 [TBL] [Abstract][Full Text] [Related]
36. Extending the phenotype associated with the CSNK2A1-related Okur-Chung syndrome-A clinical study of 11 individuals. Owen CI; Bowden R; Parker MJ; Patterson J; Patterson J; Price S; Sarkar A; Castle B; Deshpande C; Splitt M; Ghali N; Dean J; Green AJ; Crosby C; ; Tatton-Brown K Am J Med Genet A; 2018 May; 176(5):1108-1114. PubMed ID: 29383814 [TBL] [Abstract][Full Text] [Related]
37. Autosomal dominant inheritance in a recently described ZMIZ1-related neurodevelopmental disorder: Case report of siblings and an affected parent. Latchman K; Calder M; Morel D; Rhodes L; Juusola J; Tekin M Am J Med Genet A; 2020 Mar; 182(3):548-552. PubMed ID: 31833199 [TBL] [Abstract][Full Text] [Related]
38. A novel de novo MTOR gain-of-function variant in a patient with Smith-Kingsmore syndrome and Antiphospholipid syndrome. Rodríguez-García ME; Cotrina-Vinagre FJ; Bellusci M; Martínez de Aragón A; Hernández-Sánchez L; Carnicero-Rodríguez P; Martín-Hernández E; Martínez-Azorín F Eur J Hum Genet; 2019 Sep; 27(9):1369-1378. PubMed ID: 31053780 [TBL] [Abstract][Full Text] [Related]
39. A novel familial autosomal dominant mutation in ARID1B causing neurodevelopmental delays, short stature, and dysmorphic features. Smith JA; Holden KR; Friez MJ; Jones JR; Lyons MJ Am J Med Genet A; 2016 Dec; 170(12):3313-3318. PubMed ID: 27570168 [TBL] [Abstract][Full Text] [Related]
40. A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8. Yasin H; Gibson WT; Langlois S; Stowe RM; Tsang ES; Lee L; Poon J; Tran G; Tyson C; Wong CK; Marra MA; Friedman JM; Zahir FR J Hum Genet; 2019 Apr; 64(4):271-280. PubMed ID: 30670789 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]